Primary care of the renal transplant patient

Journal of General Internal Medicine

Volumn 25, Issue 7, 2010, Pages 731-740

  Gupta, Gaurav ^a   Unruh, Mark L ^b,c   Nolin, Thomas D ^b,c   Hasley, Peggy B ^b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

kidney transplantation; primary care; primary care physicians; renal transplantation; transplantation

Indexed keywords

ACARBOSE; CALCINEURIN INHIBITOR; CYCLOSPORIN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA VACCINE; EXENDIN 4; GLIPIZIDE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; INSULIN; METFORMIN; MIGLITOL; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIOGLITAZONE; PNEUMOCOCCUS VACCINE; PREDNISOLONE; RAPAMYCIN; REPAGLINIDE; ROSIGLITAZONE; SITAGLIPTIN; TACROLIMUS;

ALOPECIA; ANEMIA; BONE DISEASE; BONE MARROW SUPPRESSION; BRAIN DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CIGARETTE SMOKING; CONGESTIVE HEART FAILURE; DEPRESSION; DIABETES MELLITUS; DIARRHEA; DYSLIPIDEMIA; EDEMA; ESOPHAGITIS; GINGIVA HYPERPLASIA; GOUT; GRAFT SURVIVAL; HIRSUTISM; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CLEARANCE; KIDNEY GRAFT; LIFESTYLE MODIFICATION; MORTALITY; NEOPLASM; NEPHROTOXICITY; NEUROTOXICITY; OBESITY; OSTEOPOROSIS; PHYSICIAN; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; PRIMARY MEDICAL CARE; RENAL GRAFT DYSFUNCTION; REVIEW; SMOKING CESSATION; URINARY TRACT INFECTION; WOUND HEALING IMPAIRMENT;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS; HUMANS; KIDNEY TRANSPLANTATION; PHYSICIAN'S ROLE; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; RISK FACTORS; SURVIVAL RATE;

EID: 77954386891     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-010-1354-5     Document Type: Review

References (188)

1. M Suthanthiran TB Strom 1994 Renal transplantation N Engl J Med. 331 6 365 376 7832839
2. Organ Procurement and Transplant Network/Scientific Registry of Transplant Recipients Annual Report. 2007 Donation and transplantation trends. accessed in March 2009 from www.unos.org.
3. Cecka JM. The OPTN/UNOS Renal Transplant Registry. Clin Transpl. 2005:1-16
4. AJ Collins B Kasiske C Herzog, et al. 2007 Excerpts from the United States Renal Data System 2006 Annual Data Report Am J Kidney Dis. 49 1 Suppl 1 A6-7 S1-296
5. S Hariharan CP Johnson BA Bresnahan SE Taranto MJ McIntosh D Stablein 2000 Improved graft survival after renal transplantation in the United States, 1988 to 1996 N Engl J Med. 342 9 605 612 10699159
6. TM McCashland 2001 Posttransplantation care: role of the primary care physician versus transplant center Liver Transpl. 7 11 Suppl 1 S2 S12 11689771
7. S Aakhus K Dahl TE Wideroe 2004 Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-year follow-up Clin Transplant. 18 5 596 604 15344967
8. RN Foley PS Parfrey MJ Sarnak 1998 Epidemiology of cardiovascular disease in chronic renal disease J Am Soc Nephrol. 9 12 Suppl S16 S23 11443763
9. S Aakhus K Dahl TE Wideroe 1999 Cardiovascular morbidity and risk factors in renal transplant patients Nephrol Dial Transplant. 14 3 648 654 10193814
10. KL Lentine MA Schnitzler KC Abbott, et al. 2005 De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications Am J Kidney Dis. 46 4 720 733 16183428
11. KC Abbott IO Hypolite P Hshieh D Cruess AJ Taylor LY Agodoa 2002 Hospitalized congestive heart failure after renal transplantation in the United States Ann Epidemiol. 12 2 115 122 11880219 (Pubitemid 34204115)
12. BL Kasiske JR Maclean JJ Snyder 2006 Acute myocardial infarction and kidney transplantation J Am Soc Nephrol. 17 3 900 907 16481414
13. AO Ojo 2006 Cardiovascular complications after renal transplantation and their prevention Transplantation. 82 5 603 611 16969281
14. R Marcen 2006 Cardiovascular risk factors in renal transplantation- current controversies Nephrol Dial Transplant 21 Suppl 3 iii3 iii8 16815854
15. BL Kasiske HA Chakkera J Roel 2000 Explained and unexplained ischemic heart disease risk after renal transplantation J Am Soc Nephrol. 11 9 1735 1743 10966499
16. D Ducloux C Ruedin R Gibey, et al. 1998 Prevalence, determinants, and clinical significance of hyperhomocyst(e)inaemia in renal-transplant recipients Nephrol Dial Transplant. 13 11 2890 2893 9829496
17. M Varagunam H Finney R Trevitt, et al. 2004 Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients Am J Kidney Dis. 43 3 502 507 14981609
18. G Fernandez-Fresnedo R Escallada E Rodrigo, et al. 2002 The risk of cardiovascular disease associated with proteinuria in renal transplant patients Transplantation. 73 8 1345 1348 11981434 (Pubitemid 34454288)
19. KL Lentine LA Rocca-Rey 2008 Bacchi G, et al Obesity and cardiac risk after kidney transplantation: experience at one center and comprehensive literature review. Transplantation. 86 2 303 312
20. AN Friedman DC Miskulin IH Rosenberg AS Levey 2003 Demographics and trends in overweight and obesity in patients at time of kidney transplantation Am J Kidney Dis. 41 2 480 487 12552513
21. CL Baum K Thielke E Westin E Kogan L Cicalese E Benedetti 2002 Predictors of weight gain and cardiovascular risk in a cohort of racially diverse kidney transplant recipients Nutrition. 18 2 139 146 11844645
22. KA Armstrong SB Campbell CM Hawley DL Nicol DW Johnson NM Isbel 2005 Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients American J Transplantation. 5 11 2710 2718
23. T Shah A Kasravi E Huang, et al. 2006 Risk factors for development of new-onset diabetes mellitus after kidney transplantation Transplantation. 82 12 1673 1676 17198258
24. CS Modlin SM Flechner M Goormastic, et al. 1997 Should obese patients lose weight before receiving a kidney transplant? Transplantation 64 4 599 604 9293872
25. JL Gore PT Pham GM Danovitch, et al. 2006 Obesity and outcome following renal transplantation Am J Transplant. 6 2 357 363 16426321
26. RM Jindal ET Zawada Jr 2004 Obesity and kidney transplantation Am J Kidney Dis 43 6 943 952 15168374
27. IM Lopes M Martin P Errasti JA Martinez 1999 Benefits of a dietary intervention on weight loss, body composition, and lipid profile after renal transplantation Nutrition 15 1 7 10 9918055
28. PL Painter L Hector K Ray, et al. 2003 Effects of exercise training on coronary heart disease risk factors in renal transplant recipients Am J Kidney Dis. 42 2 362 369 12900820
29. Z Li M Maglione W Tu, et al. 2005 Meta-analysis: pharmacologic treatment of obesity Ann Intern Med. 142 7 532 546 15809465
30. D Barbaro P Orsini S Pallini F Piazza C Pasquini 2002 Obesity in transplant patients: case report showing interference of orlistat with absorption of cyclosporine and review of literature Endocr Pract. Mar-Apr 8 2 124 126
31. KA Modanlou U Muthyala H Xiao, et al. 2009 Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review Transplantation. 87 8 1167 1173 19384163
32. JW Alexander H Goodman 2007 Gastric bypass in chronic renal failure and renal transplant Nutr Clin Pract. 22 1 16 21 17242450
33. CC Rogers RR Alloway JW Alexander M Cardi J Trofe AA Vinks 2008 Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study Clinical Transplantation. May-Jun 22 3 281 291
34. B Ablassmaier S Klaua CA Jacobi JM Muller 2002 Laparoscopic gastric banding after heart transplantation Obes Surg. 12 3 412 415 12082899
35. AN Koshy JS Coombes S Wilkinson RG Fassett 2008 Laparoscopic gastric banding surgery performed in obese dialysis patients prior to kidney transplantation Am J Kidney Dis. 52 4 e15 e17 18617303
36. H Weiss H Nehoda B Labeck M Oberwalder A Konigsrainer R Margreiter 2000 Organ transplantation and obesity: evaluation, risks and benefits of therapeutic strategies Obes Surg. 10 5 465 469 11054253
37. KE Buch R El-Sabrout KM Butt 2006 Complications of laparoscopic gastric banding in renal transplant recipients: a case study Transplant Proc. 38 9 3109 3111 17112911
38. IG Olarte A Hawasli 2009 Kidney transplant complications and obesity Am J Surg. 197 3 424 426 19245927
39. BG Duffey RN Pedro A Makhlouf, et al. 2008 Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis J Am Coll Surg. 206 3 1145 1153 18501812
40. JC Lieske R Kumar ML Collazo-Clavell 2008 Nephrolithiasis after bariatric surgery for obesity Semin Nephrol. 28 2 163 173 18359397
41. MK Sinha ML Collazo-Clavell A Rule, et al. 2007 Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery Kidney Int. 72 1 100 107 17377509
42. BL Kasiske D Klinger 2000 Cigarette smoking in renal transplant recipients J Am Soc Nephrol. 11 4 753 759 10752535
43. RS Sung M Althoen TA Howell AO Ojo RM Merion 2001 Excess risk of renal allograft loss associated with cigarette smoking Transplantation. 71 12 1752 1757 11455254
44. MC Banas B Banas J Wolf, et al. 2008 Smoking behaviour of patients before and after renal transplantation Nephrol Dial Transplant. 23 4 1442 1446 18065794
45. Strategies for reducing exposure to environmental tobacco smoke, increasing tobacco-use cessation, and reducing initiation in communities and health-care systems. A report on recommendations of the Task Force on Community Preventive Services. MMWR Recomm Rep. Nov 10 2000;49(RR-12):1-11.
46. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004;(3):CD000146.
47. BR Lewis SL Aoun GA Bernstein SJ Crow 2001 Pharmacokinetic interactions between cyclosporine and bupropion or methylphenidate J Child Adolesc Psychopharmacol. Summer 11 2 193 198
48. DE Jorenby JT Hays NA Rigotti, et al. 2006 Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial JAMA 296 1 56 63 16820547
49. AC Shirali MJ Bia 2008 Management of cardiovascular disease in renal transplant recipients Clin J Am Soc Nephrol. 3 2 491 504 18287250
50. RS McIntyre 2008 Varenicline and suicidality: a new era in medication safety surveillance Expert Opin Drug Saf. 7 5 511 514 18759703
51. JB McClure GE Swan L Jack, et al. 2009 Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline J Gen Intern Med. 24 5 563 569 19238488
52. AV Chobanian GL Bakris HR Black, et al. 2003 The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure-The JNC 7 Report JAMA 289 19 2560 2572 12748199
53. BL Kasiske S Anjum R Shah, et al. 2004 Hypertension after kidney transplantation Am J Kidney Dis. 43 6 1071 1081 15168388
54. JJ Curtis 1992 Cyclosporine and Posttransplant Hypertension J Am Soc Nephrol 2 12 S243 S245 1498282
55. DL Veenstra JH Best J Hornberger SD Sullivan DE Hricik 1999 Incidence and long-term cost of steroid-related side effects after renal transplantation Am J Kidney Dis. 33 5 829 839 10213637 (Pubitemid 29214678)
56. KC Mange B Cizman M Joffe HI Feldman 2000 Arterial hypertension and renal allograft survival JAMA. 283 5 633 638 10665703
57. G Opelz T Wujciak E Ritz 1998 Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study Kidney Int. Jan 53 1 217 222
58. K/DOQI 2004 clinical practice guidelines on hypertension and anti hypertensive agents in chronic kidney disease Am J Kidney Dis. 43 5 S14 S290
59. European best practice guidelines for renal transplantation (2002) Section IV: Long-term management of the transplant recipient. IV.5.1. Cardiovascular risks. Cardiovascular disease after renal transplantation. Nephrol Dial Transplant. 17 Suppl 4:24-5.
60. CR Tomson 2003 Ambulatory blood pressure measurement in kidney transplantation: an overview Transplantation. 76 11 1643 1644 14702542
61. JP Kooman MH Christiaans JM Boots FM van Der Sande KM Leunissen JP van Hooff 2001 A comparison between office and ambulatory blood pressure measurements in renal transplant patients with chronic transplant nephropathy Am J Kidney Dis. 37 6 1170 1176 11382685
62. GW Lipkin B Tucker M Giles AE Raine 1993 Ambulatory blood pressure and left ventricular mass in cyclosporin-and non-cyclosporin-treated renal transplant recipients J Hypertens. 11 4 439 442 8390512
63. A Covic L Segall DJ Goldsmith 2003 Ambulatory blood pressure monitoring in renal transplantation: should ABPM be routinely performed in renal transplant patients? Transplantation. 76 11 1640 1642 14702541
64. NC Premasathian R Muehrer PC Brazy JD Pirsch BN Becker 2004 Blood pressure control in kidney transplantation: therapeutic implications J Hum Hypertens. 18 12 871 877 15318162
65. AJ Olyaei AM deMattos WM Bennett 1999 A practical guide to the management of hypertension in renal transplant recipients Drugs 58 6 1011 1027 10651388
66. Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. American Journal of Transplantation. 2009;9(s3):S1-55.
67. KDOQI 2007 Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease Am J Kidney Dis. 49 2 Suppl 2 S12 S154
68. K Midtvedt A Hartmann H Holdaas P Fauchald 2001 Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double-blind randomised comparative trial Clin Transplant. 15 6 426 431 11737121
69. SD Ladefoged CB Andersen 1994 Calcium channel blockers in kidney transplantation Clin Transplant. 8 2 Pt 1 128 133 8019022
70. European best practice guidelines for renal transplantation 2002 Section IV: Long-term management of the transplant recipient Nephrol Dial Transplant. 17 Suppl 4 1 67
71. J Kothari M Nash J Zaltzman Ramesh GV Prasad 2004 Diltiazem use in tacrolimus-treated renal transplant recipients J Clin Pharm Ther. Oct 29 5 425 430
72. A Djamali M Samaniego B Muth, et al. 2006 Medical care of kidney transplant recipients after the first posttransplant year Clin J Am Soc Nephrol. 1 4 623 640 17699268
73. J Buturovic-Ponikvar 2003 Renal transplant artery stenosis Nephrol Dial Transplant. 18 Suppl 5 v74 v77 12817078
74. S Valpreda M Messina C Rabbia 2008 Stenting of transplant renal artery stenosis: outcome in a single center study J Cardiovasc Surg (Torino). 49 5 565 570
75. A Voiculescu M Hollenbeck J Plum, et al. 2003 Iliac artery stenosis proximal to a kidney transplant: clinical findings, duplex-sonographic criteria, treatment, and outcome Transplantation. 76 2 332 339 12883188
76. A Voiculescu M Schmitz M Hollenbeck, et al. 2005 Management of arterial stenosis affecting kidney graft perfusion: a single-centre study in 53 patients Am J Transplant. 5 7 1731 1738 15943633
77. B Kasiske FG Cosio J Beto, et al. 2004 Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative Am J Transplant. 4 13 53 15027968
78. SCJ Chueh BD Kahan 2003 Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: Incidence, risk factors, progression, and prognosis Transplantation. 76 2 375 382 12883196
79. JA Kobashigawa BL Kasiske 1997 Hyperlipidemia in solid organ transplantation Transplantation. 63 3 331 338 9039919
80. C Legendre JM Campistol JP Squifflet JT Burke 2003 Cardiovascular risk factors of sirolimus compared with cyclosporine: early experience from two randomized trials in renal transplantation Transplant Proc. 35 3 Suppl 151S 153S 12742488
81. B Fellstrom 2001 Risk factors for and management of post-transplantation cardiovascular disease BioDrugs. 15 4 261 278 11437691
82. C Brattstrom H Wilczek G Tyden Y Bottiger J Sawe CG Groth 1998 Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin) Transplantation. 65 9 1272 1274 9603181 (Pubitemid 28224351)
83. BL Kasiske 1988 Risk factors for accelerated atherosclerosis in renal transplant recipients Am J Med. 84 6 985 992 3287917
84. Third Report of the National Cholesterol Education Program (NCEP) 2002 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation. 106 25 3143 3421
85. H Holdaas B Fellstrom AG Jardine, et al. 2003 Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial Lancet. 361 9374 2024 2031 12814712
86. A Asberg 2003 Interactions between cyclosporin and lipid-lowering drugs: implications for organ transplant recipients Drugs. 63 4 367 378 12558459
87. WP Lemahieu M Hermann A Asberg, et al. 2005 Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus Am J Transplant. 5 9 2236 2243 16095503
88. J Nogueira M Weir 2007 The unique character of cardiovascular disease in chronic kidney disease and its implications for treatment with lipid-lowering drugs Clin J Am Soc Nephrol. 2 4 766 785 17699494
89. JJ Kastelein F Akdim ES Stroes, et al. 2008 Simvastatin with or without ezetimibe in familial hypercholesterolemia N Engl J Med. 358 14 1431 1443 18376000
90. AJ Langone P Chuang 2006 Ezetimibe in renal transplant patients with hyperlipidemia resistant to HMG-CoA reductase inhibitors Transplantation. 81 5 804 807 16534487
91. AK Lim KJ Manley MA Roberts MB Fraenkel 2007 Fish oil treatment for kidney transplant recipients: a meta-analysis of randomized controlled trials Transplantation. 83 7 831 838 17460552
92. CM Ballantyne A Corsini MH Davidson, et al. 2003 Risk for myopathy with statin therapy in high-risk patients Arch Intern Med. 163 5 553 564 12622602
93. S Celik A Doesch C Erbel, et al. 2008 Beneficial effect of omega-3 fatty acids on sirolimus-or everolimus-induced hypertriglyceridemia in heart transplant recipients Transplantation. 86 2 245 250 18645486
94. BL Kasiske 2005 Clinical practice guidelines for managing dyslipidemias in kidney transplant patients Am J Transplant 5 6 1576 15888073
95. BL Kasiske JJ Snyder D Gilbertson AJ Matas 2003 Diabetes mellitus after kidney transplantation in the United States Am J Transplant. 3 2 178 185 12603213
96. P Chuang EM Gibney L Chan PM Ho CR Parikh 2004 Predictors of cardiovascular events and associated mortality within two years of kidney transplantation Transplant Proc. 36 5 1387 1391 15251339
97. G Fernandez-Fresnedo R Escallada ALM de Francisco, et al. 2003 Posttransplant diabetes is a cardiovascular risk factor in renal transplant patients Transplant Proc. 35 2 700 700 12644099
98. AM Miles N Sumrani R Horowitz, et al. 1998 Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? Transplantation. 65 3 380 384 9484755
99. A Wilkinson J Davidson F Dotta, et al. 2005 Guidelines for the treatment and management of new-onset diabetes after transplantation Clin Transplant. 19 3 291 298 15877787
100. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. Jan 2003;26 Suppl 1:S5-20.
101. JS Skyler R Bergenstal RO Bonow, et al. 2009 Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association J Am Coll Cardiol. 53 3 298 304 19147051
102. HC Gerstein ME Miller RP Byington, et al. 2008 Effects of intensive glucose lowering in type 2 diabetes N Engl J Med. 358 24 2545 2559 18539917
103. NG Boule E Haddad GP Kenny GA Wells RJ Sigal 2001 Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials JAMA. 286 10 1218 1227 11559268
104. SL Seliger DL Gillen WT Longstreth Jr B Kestenbaum CO Stehman-Breen 2003 Elevated risk of stroke among patients with end-stage renal disease Kidney Int. 64 2 603 609 12846756 (Pubitemid 36871932)
105. A Oliveras J Roquer JM Puig, et al. 2003 Stroke in renal transplant recipients: epidemiology, predictive risk factors and outcome Clin Transplant. 17 1 1 8 12588314
106. S Abedini I Holme B Fellstrom, et al. 2009 Cerebrovascular events in renal transplant recipients Transplantation. 87 1 112 117 19136900
107. S Khella MB Bleicher 2007 Stroke and its prevention in chronic kidney disease Clin J Am Soc Nephrol. 2 6 1343 1351 17942760
108. N Shah S Al-Khoury B Afzali, et al. 2006 Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors Transplantation. 81 8 1112 1118 16641595
109. Y Vanrenterghem 2004 Anaemia after renal transplantation Nephrology Dialysis Transplantation. 19 54 58
110. C Rigatto R Foley J Jeffery C Negrijn C Tribula P Parfrey 2003 Electrocardiographic left ventricular hypertrophy in renal transplant recipients: Prognostic value and impact of blood pressure and anemia J Am Soc Nephrol. 14 2 462 468 12538748
111. WC Winkelmayer A Chandraker 2008 Pottransplantation anemia: management and rationale Clin J Am Soc Nephrol. 3 Suppl 2 S49 S55 18309003
112. Y Vanrenterghem C Ponticelli JM Morales, et al. 2003 Prevalence and management of anemia in renal transplant recipients: a European survey Am J Transplant. 3 7 835 845 12814475
113. M Lorenz J Kletzmayr A Perschl A Furrer WH Horl G Sunder-Plassmann 2002 Anemia and iron deficiencies among long-term renal transplant recipients J Am Soc Nephrol. 13 3 794 797 11856787
114. B Afzali S Al-Khoury N Shah A Mikhail A Covic D Goldsmith 2006 Anemia after renal transplantation Am J Kidney Dis. 48 4 519 536 16997048
115. S Pamidi K Friedman B Kampalath C Eshoa S Hariharan 2000 Human parvovirus B19 infection presenting as persistent anemia in renal transplant recipients Transplantation. 69 12 2666 2669 10910292
116. BL Kasiske MA Vazquez WE Harmon, et al. 2000 Recommendations for the outpatient surveillance of renal transplant recipients J Am Soc Nephrol. 11 10 S1 S86 11044969
117. II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults. Am J Kidney Dis. May 2006;47(5 Suppl 3):S16-85.
118. KDOQI 2007 Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target Am J Kidney Dis. 50 3 471 530
119. KC Abbott PL Kimmel V Dharnidharka RJ Oglesby LY Agodoa S Caillard 2005 New-onset gout after kidney transplantation: incidence, risk factors and implications Transplantation. 80 10 1383 1391 16340779
120. HY Lin LL Rocher MA McQuillan S Schmaltz TD Palella IH Fox 1989 Cyclosporine-induced hyperuricemia and gout N Engl J Med. 321 5 287 292 2664517
121. WE Braun 2000 Modification of the treatment of gout in renal transplant recipients Transplant Proc 32 1 199 10701023
122. L Stamp M Searle J O'Donnell P Chapman 2005 Gout in solid organ transplantation: a challenging clinical problem Drugs. 65 18 2593 2611 16392875
123. P Dupont I Hunt L Goldberg A Warrens 2002 Colchicine myoneuropathy in a renal transplant patient Transpl Int. 15 7 374 376 12122515
124. RW Kuncl G Duncan D Watson K Alderson MA Rogawski 1987 Peper M. Colchicine myopathy and neuropathy N Engl J Med. 316 25 1562 1568 3035372
125. JA Alloway MJ Moriarty YT Hoogland DJ Nashel 1993 Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis J Rheumatol. 20 1 111 113 8441139
126. AK Rosenthal LM Ryan 1995 Treatment of refractory crystal-associated arthritis Rheum Dis Clin North Am. 21 1 151 161 7732165
127. N Dalbeth L Stamp 2007 Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events Semin Dial. Sep-Oct 20 5 391 395
128. D Cummins M Sekar O Halil N Banner 1996 Myelosuppression associated with azathioprine-allopurinol interaction after heart and lung transplantation Transplantation. 61 11 1661 1662 8669118
129. B Arapaslan A Soykan C Soykan H Kumbasar 2004 Cross-sectional assessment of psychiatric disorders in renal transplantation patients in Turkey: a preliminary study Transplant Proc. 36 5 1419 1421 15251349
130. JA Butler RC Peveler P Roderick PW Smith R Horne JC Mason 2004 Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: a cross-sectional study Nephrol Dial Transplant. 19 12 3144 3149 15479748
131. F Dobbels MA Skeans JJ Snyder AV Tuomari JR Maclean BL Kasiske 2008 Depressive disorder in renal transplantation: an analysis of Medicare claims Am J Kidney Dis. 51 5 819 828 18436093
132. Cukor D, Rosenthal DS, Jindal RM, Brown CD, Kimmel PL. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int. 2009.
133. HL Liston JS Markowitz N Hunt CL DeVane DW Boulton E Ashcraft 2001 Lack of citalopram effect on the pharmacokinetics of cyclosporine Psychosomatics. Jul-Aug 42 4 370 372
134. LS Baines JT Joseph RM Jindal 2004 Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants Kidney Int. 65 5 1937 1942 15086937
135. U Kunzendorf BK Kramer W Arns, et al. 2008 Bone disease after renal transplantation Nephrol Dial Transplant. 23 2 450 458 18056071
136. S Patel JT Kwan E McCloskey, et al. 2001 Prevalence and causes of low bone density and fractures in kidney transplant patients J Bone Miner Res. 16 10 1863 1870 11585351
137. WH Grotz FA Mundinger B Gugel V Exner G Kirste PJ Schollmeyer 1994 Bone fracture and osteodensitometry with dual energy X-ray absorptiometry in kidney transplant recipients Transplantation. 58 8 912 915 7940734
138. JR Weisinger RG Carlini E Rojas E Bellorin-Font 2006 Bone disease after renal transplantation Clin J Am Soc Nephrol. 1 6 1300 1313 17699362
139. K/DOQI, 2003 clinical practice guidelines for bone metabolism and disease in chronic kidney disease Am J Kidney Dis. 42 4 Suppl 3 S1 S201
140. S Hariharan 2006 Recommendations for outpatient monitoring of kidney transplant recipients Am J Kidney Dis. 47 4 Suppl 2 S22 S36 16567238
141. Palmer SC, McGregor DO, Strippoli GF Interventions for preventing bone disease in kidney transplant recipients. Cochrane Database Syst Rev. 2007;(3):CD005015.
142. DN Cruz HM Brickel JJ Wysolmerski, et al. 2002 Treatment of osteoporosis and osteopenia in long-term renal transplant patients with alendronate Am J Transplant. 2 1 62 67 12095058
143. JR Jeffery WD Leslie ME Karpinski PW Nickerson DN Rush 2003 Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate Transplantation. 76 10 1498 1502 14657693
144. BL Kasiske JJ Snyder DT Gilbertson C Wang 2004 Cancer after kidney transplantation in the United States Am J Transplant. 4 6 905 913 15147424
145. CM Vajdic SP McDonald MR McCredie, et al. 2006 Cancer incidence before and after kidney transplantation JAMA. 296 23 2823 2831 17179459
146. CD Wimmer M Rentsch A Crispin, et al. 2007 The janus face of immunosuppression-de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich Kidney Int. 71 12 1271 1278 17332737
147. AE Grulich MT van Leeuwen MO Falster CM Vajdic 2007 Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis Lancet. 370 9581 59 67 17617273
148. D Serraino P Piselli G Busnach, et al. 2007 Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe Eur J Cancer. 43 14 2117 2123 17764927
149. C Morath M Mueller H Goldschmidt V Schwenger G Opelz M Zeier 2004 Malignancy in renal transplantation J Am Soc Nephrol. 15 6 1582 1588 15153569
150. M Fischereder 2008 Cancer in patients on dialysis and after renal transplantation Nephrol Dial Transplant. 23 8 2457 2460 18398015
151. J Dantal E Pohanka 2007 Malignancies in renal transplantation: an unmet medical need Nephrol Dial Transplant. 22 Suppl 1 i4 i10 17456618
152. European best practice guidelines for renal transplantation 2002 Section IV: Long-term management of the transplant recipient. IV.6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment Nephrol Dial Transplant. 17 (Suppl)4 31 36
153. G Knoll 2008 Trends in kidney transplantation over the past decade Drugs. 68 Suppl 1 3 10 18442296
154. JA Fishman 2007 Infection in solid-organ transplant recipients N Engl J Med. 357 25 2601 2614 18094380
155. A Padiyar FH Akoum DE Hricik 2008 Management of the kidney transplant recipient Prim Care. 35 3 433 450 18710663
156. KC Abbott SJ Swanson ER Richter, et al. 2004 Late urinary tract infection after renal transplantation in the United States Am J Kidney Dis. 44 2 353 362 15264195
157. LE Nicolle S Bradley R Colgan JC Rice A Schaeffer TM Hooton 2005 Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults Clin Infect Dis. 40 5 643 654 15714408
158. D Grekas V Thanos C Dioudis P Alivanis A Tourkantonis 1993 Treatment of urinary tract infections with ciprofloxacin after renal transplantation Int J Clin Pharmacol Ther Toxicol. 31 6 309 311 8335429
159. RM de Souza J Olsburgh 2008 Urinary tract infection in the renal transplant patient Nat Clin Pract Nephrol. 4 5 252 264 18334970
160. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant. Nov 2004;4 Suppl 10:160-3.
161. A Duchini JA Goss S Karpen PJ Pockros 2003 Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols Clin Microbiol Rev. 16 3 357 364 12857772
162. RK Avery M Michaels 2008 Update on immunizations in solid organ transplant recipients: what clinicians need to know Am J Transplant. 8 1 9 14 18093271
163. HP Tan DJ Kaczorowski A Basu, et al. 2006 Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy Am J Transplant. 6 10 2409 2417 16889606
164. HU Meier-Kriesche S Li RW Gruessner, et al. 2006 Immunosuppression: evolution in practice and trends, 1994-2004 Am J Transplant. 6 5 Pt 2 1111 1131 16613591
165. SM Arend MJ Mallat RJ Westendorp FJ van der Woude LA van Es 1997 Patient survival after renal transplantation; more than 25 years follow-up Nephrol Dial Transplant. 12 8 1672 1679 9269647
166. PS Rao DE Schaubel X Jia S Li FK Port R Saran 2007 Survival on dialysis post-kidney transplant failure: results from the Scientific Registry of Transplant Recipients Am J Kidney Dis. 49 2 294 300 17261432
167. AO Ojo JA Hanson RA Wolfe AB Leichtman LY Agodoa FK Port 2000 Long-term survival in renal transplant recipients with graft function Kidney Int. 57 1 307 313 10620213
168. JA Cutler PD Sorlie M Wolz T Thom LE Fields EJ Roccella 2008 Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004 Hypertension. 52 5 818 827 18852389
169. From the Centers for Disease Control and Prevention, Physician and other health care professional counseling of smokers to quit-United States, 1991. JAMA. Dec 1 1993;270(21):2536-7.
170. J Coresh E Selvin LA Stevens, et al. 2007 Prevalence of chronic kidney disease in the United States JAMA. 298 17 2038 2047 17986697 (Pubitemid 350074801)
171. CDC 2006 State-Specific Prevalence of Obesity Among Adults-United States, 2005 Morbidity and Mortality Weekly Report. 55 36 985 988
172. DC Goff Jr AG Bertoni H Kramer, et al. 2006 Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium Circulation. 113 5 647 656 16461837
173. National Health and Nutrition Examination Survey (NHANES) 2004-2006. accessed in March, 2009 from http://www.cdc.gov/nchs/about/major/nhanes/ nhanes2005-2006/nhanes05-06.htm.
174. RN Foley AM Murray S Li, et al. 2005 Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999 J Am Soc Nephrol. 16 2 489 495 15590763
175. BL Kasiske 2000 Cardiovascular disease after renal transplantation Semin Nephrol. 20 2 176 187 10746859
176. MR First JF Neylan LL Rocher A Tejani 1994 Hypertension after renal transplantation J Am Soc Nephrol. 4 8 Suppl S30 S36 8193293
177. AM Lincoff K Wolski SJ Nicholls SE Nissen 2007 Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials JAMA. 298 10 1180 1188 17848652
178. RM Lago PP Singh RW Nesto 2007 Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials Lancet. 370 9593 1129 1136 17905165
179. SE Nissen K Wolski 2007 Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes N Engl J Med. 356 24 2457 2471 17517853
180. JC Chan R Scott 2008 Arjona Ferreira JC, et al. Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency Diabetes Obes Metab. 10 7 545 555 18518892
181. A Djamali 2008 Can the renal transplant patient be really considered as a patient with chronic renal insufficiency? Nephrol Ther. 4 Suppl 1 S36 S39 18703397
182. A Schwarz S Vatandaslar S Merkel H Haller 2007 Renal cell carcinoma in transplant recipients with acquired cystic kidney disease Clin J Am Soc Nephrol. 2 4 750 756 17699492
183. KA Birdwell MR Ikizler EC Sannella, et al. 2009 Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study Am J Kidney Dis. 54 1 112 121 19185404
184. AI Sanchez-Fructuoso D Prats P Naranjo, et al. 2000 Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: mycophenolate versus azathioprine Transplantation. 69 3 436 439 10706057
185. JF Bernardo J McCauley 2004 Drug therapy in transplant recipients: special considerations in the elderly with comorbid conditions Drugs Aging. 21 5 323 348 15040759
186. JJ Augustine KA Bodziak DE Hricik 2007 Use of sirolimus in solid organ transplantation Drugs. 67 3 369 391 17335296
187. CE Staatz SE Tett 2007 Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients Clin Pharmacokinet. 46 1 13 58 17201457
188. DR Kuypers 2009 Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions Drugs Aging. 26 9 715 737 19728747